Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Procurement and Distribution of Study Medicines

Go back to Resources

Procurement and Distribution of Study Medicines

Authors:

Secondary:

Publisher:

Editor(s):

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Leveraging electronic data capture (EDC) systems to optimize pharmacovigilance in clinical trials

Go back to Resources

Leveraging electronic data capture (EDC) systems to optimize pharmacovigilance in clinical trials

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Developing a web-based central laboratory shipment scheduler and information system

Go back to Resources

Developing a web-based central laboratory shipment scheduler and information system

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Considering sex as a biological variable in research design, data analyses and reporting

Go back to Resources

Considering sex as a biological variable in research design, data analyses and reporting

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Go back to Resources

Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Go back to Resources

Tailoring a comprehensive website to support a clinical research network

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Go back to Resources

The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Go back to Resources

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Authors:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Reply

Go back to Resources

Reply

Authors:

Journal:

PMID:

URL:

DOI:

Go back to Resources

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

Go back to Resources

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

Authors:

Volume:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 237
  • Page 238
  • Page 239
  • Page 240
  • Current page 241
  • Page 242
  • Page 243
  • Page 244
  • Page 245
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification